Janet Snell-Bergeon MPH PhD

  • Anschutz Campus - Sch of Med - BDC Clinical EPI Research

Email Address:janet.snell-bergeon@cuanschutz.edu

Primary Phone:303-724-6762

Mailing Address:
  • CU Anschutz

Barbara Davis Center for Diabetes

1775 North Aurora Court

Aurora, CO 80045

Dr. Snell-Bergeon joined the BDC faculty in 2008. Her area of interest is the complications of type 1 diabetes. As an investigator and current PI of the Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study, she has contributed to understanding the mechanisms through which hyperglycemia and insulin resistance increase cardiovascular risk in type 1 diabetes and has recently examined insulin resistance in women with type 1 diabetes in relationship with measures of arterial stiffness in an American Diabetes Association (ADA) Junior Faculty Award.  She is the PI of an ADA Career Development Award with the goal of examining how estrogen affects vascular health and complications in young women with T1D compared to non-diabetic women.   She is the Denver site PI for a JDRF network grant investigating novel proteomic, metabolomic and lipidomic markers of diabetic kidney disease, and the Denver site PI for a study of HDL function in cardiovascular disease risk among adults with T1D.   In collaboration with Dr. Irene Schauer, she is examining novel adjunct therapies to improve glycemic control in adults and adolescents with type 1 diabetes. She is mentoring Dr. Viral Shah on a pilot grant investigating bone health in postmenopausal women with and without T1D, and has just received a pilot grant to examine how reproductive hormones affect vascular and bone health in women with T1D. She is a co-investigator for the Diabetes Autoimmunity Study in the Young (DAISY), and has contributed to papers with The Environmental Determinants of Type 1 Diabetes (TEDDY) and SEARCH for Diabetes in Youth studies.

Education, Licensure & Certifications

PhD: University of Colorado, Denver (2007)
Fellowships: University of Colorado, Denver (2009)

CMS Login